Details of the Drug Formulations

General Information of Drug (ID: DM602WT)

• Drug Name: Idelalisib Drug Info
• Synonyms: Idelalisib; 870281-82-6; CAL-101; Zydelig; GS-1101; CAL101; CAL 101; (S)-2-(1-((9H-Purin-6-yl)amino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one; UNII-YG57I8T5M0; CAL-101 (Idelalisib, GS-1101); YG57I8T5M0; CHEMBL2216870; CHEBI:82701; 5-Fluoro-3-phenyl-2-((S)-1-(9H-purin-6-ylamino)-propyl)-3H-quinazolin-4-one; AK145603; Idelalisib; CAL-101; (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one; 1146702-54-6; 5-FLUORO-3-PHENYL-2-[(1S)-1-(9H-PURIN-6-YLAMINO)PROPYL]-4(3H)-QUINAZOLINONE

Indication

Disease Entry	ICD 11	Status	REF
Chronic lymphocytic leukaemia	2A82.0	Approved	[1]
Small lymphocytic lymphoma	2A82.0	Approved	[2]
Follicular lymphoma	2A80	Investigative	[2]

• Cross-matching ID:
  PubChem CID: 11625818
  ChEBI ID: CHEBI:82701
  CAS Number: 870281-82-6
  TTD ID: D0J5VR
  VARIDT ID: DR00219
  INTEDE ID: DR0854
  ACDINA ID: D00322

Full List of Drug Formulations Containing This Drug

Idelalisib 100 mg tablet

Company	Formulation ID	FDA Description
Gilead Sciences	F10476	Fd&c yellow no. 6; Magnesium stearate; Talc; Titanium dioxide; Croscarmellose sodium; Aluminum oxide; Hydroxypropyl cellulose (1200000 mw); Microcrystalline cellulose; Polyethylene glycol, unspecified; Polyvinyl alcohol, unspecified; Sodium starch glycolate type a potato

Idelalisib 150 mg tablet

Company	Formulation ID	FDA Description
Gilead Sciences	F10477	Magnesium stearate; Ferric oxide red; Talc; Titanium dioxide; Croscarmellose sodium; Hydroxypropyl cellulose (1200000 mw); Microcrystalline cellulose; Polyethylene glycol, unspecified; Polyvinyl alcohol, unspecified; Sodium starch glycolate type a potato

References

• [1] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6741).
• [2] Idelalisib FDA Label